Internal Medicine, Infectious Disease · Somers Point, NJ
NPI
1467447417
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
730 Shore Rd
Somers Point, NJ, 08244
Phone (609) 927-6662
Groups this clinician bills Medicare through
Medicare paid, 2024
$594K
133,436 services
Medicare patients, 2024
899
Average age 75
Drug cost, 2024
$4.4M
3,276 prescriptions
Company payments, 2025
$16K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher Lucasti was code J0878 (injection, daptomycin, 1 mg), 106,226 times for 15 patients. In total Christopher Lucasti billed 133,436 services in 62 codes, and Medicare paid $594K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 106,226 | 15 | $0.05 | $4,976 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 7,599 | 79 | $0.36 | $2,741 |
| J0692 Injection, cefepime hydrochloride, 500 mg | Office | 3,243 | 35 | $0.99 | $3,211 |
| 96365 Intravenous Infusion, Hydration | Office | 2,141 | 167 | $52.95 | $113K |
| J3370 Injection, vancomycin hcl, 500 mg | Office | 1,988 | 47 | $1.74 | $3,459 |
| J0690 Injection, cefazolin sodium, 500 mg | Office | 1,798 | 11 | $0.64 | $1,147 |
| J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | Office | 1,504 | 16 | $0.87 | $1,305 |
| 99232 Hospital E&M - Subsequent | Facility | 1,114 | 419 | $62.74 | $70K |
| 96521 Chemotherapy | Office | 825 | 51 | $106.52 | $88K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 726 | 43 | $8.75 | $6,355 |
| 99223 Hospital E&M - Initial | Facility | 451 | 396 | $136.14 | $61K |
| 99214 Office E&M - Established | Office | 402 | 189 | $98.69 | $40K |
| 96367 Intravenous Infusion, Hydration | Office | 321 | 29 | $24.09 | $7,734 |
| 99213 Office E&M - Established | Office | 278 | 183 | $67.91 | $19K |
| 99183 Hyperbaric Oxygen | Facility | 252 | 14 | $85.81 | $22K |
By year: 2022 $611K for 93,874 services; 2023 $507K for 118,597 services; 2024 $594K for 133,436 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher Lucasti prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 271 prescriptions and refills. In total Christopher Lucasti wrote 3,276 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 271 | 299 | 33 | $1.2M |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 163 | 163 | 15 | $597K |
| Doxycycline Hyclate Generic | 138 | 142 | 72 | $2,070 |
| Cephalexin Generic | 112 | 124 | 71 | $634 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 79 | 101 | 51 | $1,145 |
| Tivicay Dolutegravir Sodium | 79 | 81 | 11 | $185K |
| Ciprofloxacin Hcl Generic | 76 | 76 | 55 | $516 |
| Cefadroxil Generic | 66 | 80 | 17 | $1,374 |
| Methenamine Hippurate Generic | 65 | 81 | 15 | $3,028 |
| Prezcobix Darunavir/Cobicistat | 64 | 64 | Under 11 | $156K |
| Ceftriaxone Ceftriaxone Sodium | 59 | 59 | 16 | $4,826 |
| Azithromycin Generic | 57 | 64 | 16 | $631 |
| Valacyclovir Valacyclovir Hcl | 55 | 85 | 11 | $1,214 |
| Fluconazole Generic | 55 | 60 | 28 | $327 |
| Ethambutol Hcl Generic | 52 | 59 | Under 11 | $1,053 |
Brand drugs: - claims; generic drugs: 2,077 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher Lucasti $16K ($16K in general payments such as food, travel and fees) from 21 companies. The largest payer was Gilead Sciences, Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 54 | $14K |
| ViiV Healthcare Company GSK | 24 | $508 |
| Abbvie Inc. ABBV | 26 | $461 |
| Smith+Nephew, Inc. SNN | 15 | $153 |
| Insmed, Inc. INSM | 7 | $128 |
| Cumberland Pharmaceuticals, Inc. CPIX | 6 | $111 |
| Merck Sharp & Dohme LLC MRK | 6 | $107 |
| Paratek Pharmaceuticals, Inc. | 6 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $105 |
| EMD Serono, Inc. MRK.DE | 5 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.